TrialAnnals of surgical oncology2015

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

Piotr Rutkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.